Navigation Links
MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
Date:3/14/2008

Presentation will be webcast live and archived on Company's web site

GERMANTOWN, Md., March 14 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that Dr. Edward M. Rudnic, MiddleBrook president and CEO, will deliver a corporate presentation on Tuesday, March 18, 2008, at 4:45 p.m. Eastern Time.

The presentation will take place as part of the Lehman Brothers Eleventh Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida. Dr. Rudnic's remarks will be available live on the MiddleBrook web site, where they also will be archived for 30 days.

To access the presentation, log on to http://www.middlebrookpharma.com and click on the Presentations option in the Investor Relations section. Please connect to the web site several minutes prior to the start of the live presentation to ensure adequate time for any software download that may be necessary.

About MiddleBrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front- loaded st
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., NEW YORK, Nov. 30 Th...ch (MJFF) today announced $1.5 million in total aw...ntially disease-modifying therapies for Parkinson,...l Approaches to Drug Discovery for Parkinson,s Dis...Corporation, plc (NYSE: ELN ), a neuroscience-ba...
(Date:11/30/2009)..., AMSTERDAM, November 30 Biop...y that the first patients have been enrolled in it...TIR(TM). The study is,designed to show reduction i...r following an allogeneic stem cell transplantatio...od cancer patients eligible for an allogeneic,stem...
(Date:11/30/2009)..., ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ ...it has completed enrollment in the Phase II clinic.../2009 recommended strains) VLP vaccine candidate i...dults). This randomized, double-blind, active-con...y and immunogenicity of two different doses (15 mc...
(Date:11/30/2009)... , SEATTLE, Nov. 30 ...IC) announced today that its new class of platinum..., demonstrated a stronger anti-tumor potency and a...ased compounds as well as the ability to overcome ...sults were presented in a paper titled "Novel Bis-...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
... high-throughput screening of HSV , , Cindy ...elanie Palmer Dwight DuBois ,Stratagene , Str...etection,module, * , , ff ,a single-tube ...) DNA. Because,it is performed in a closed-tube ...ation, HSV detection is simplified, and the risk o...
...n PCR system, developed for,highfidelity PCR ,...Bai * Daniel McMullan,* Barbara McGowan * Holly ..., Stratagene announces the addition of the TaqPlus... PCR products. The TaqPlus Precision PCR system,... polymerases and a reaction,buffer that has been...
...w plasmid library construction,kits , , ...Neiditch Alan Greener John C. Bauer Mike Kobrin... II,pcmv-script and pAD-GAL4-2.1 XR library co...As and high-efficiency transformation into Epicuri...,Plasmid cDNA libraries constructed with XL10-Go...
Other Biology Technology:HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 2HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 3HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 4High-Fidelity PCR with a Novel Polymerase Mixture 2High-Fidelity PCR with a Novel Polymerase Mixture 3High-Fidelity PCR with a Novel Polymerase Mixture 4High-Fidelity PCR with a Novel Polymerase Mixture 5High-Fidelity PCR with a Novel Polymerase Mixture 6High-Fidelity PCR with a Novel Polymerase Mixture 7High-Fidelity PCR with a Novel Polymerase Mixture 8High-Fidelity PCR with a Novel Polymerase Mixture 9High-Fidelity PCR with a Novel Polymerase Mixture 10High-Fidelity PCR with a Novel Polymerase Mixture 11Generate High-Quality, Directional Plasmid cDNA Libraries 2Generate High-Quality, Directional Plasmid cDNA Libraries 3Generate High-Quality, Directional Plasmid cDNA Libraries 4Generate High-Quality, Directional Plasmid cDNA Libraries 5Generate High-Quality, Directional Plasmid cDNA Libraries 6Generate High-Quality, Directional Plasmid cDNA Libraries 7
(Date:11/30/2009)...A new scientific organisation is needed to monitor...ountries at Copenhagen to cut their deforestation ...Leeds. , Existing government agencies and resear...sands of satellite images of the Earth,s surface c..., Now, a paper published by Dr Alan Grainger in ...
(Date:11/30/2009)..., CLEMSON Clemson University researchers Ron Falt...ronmental Protection Agency grant to study the saf...ns located deep below the earth,s surface. , Wit...ls believed to be the leading cause of global warm...t promising alternatives for reducing emissions us...
(Date:11/30/2009)... This release is available in German . , Th...laborative Research Centres as of 1 January 2010. ...ants Committee in Bonn. The new centres will initi...million. In addition, 20 percent overhead funding ...project. The centres, research topics range from m...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9African Americans with colorectal cancer have poorer outcomes lower survival rates 61245 1African Americans with colorectal cancer have poorer outcomes lower survival rates 61245 2Underground mine ventilation subject of study 61242 1Underground mine ventilation subject of study 61242 2Springer launches new journal Food Digestion 10708 1Springer launches new journal Food Digestion 10708 2
...Stevens Institute of Technology Professor Xiaojun ...nal Research Award in Biomedical Engineering from ... support his research titled, Novel structured nan...nt Professor in the Department of Chemical, Biomed... School of Engineering and Science, is focusing hi...
...-- The National Institutes of Health has selected ...TMB) Assistant Professor of Neurology Pedro Fernan... Directors New Innovator Award. , NIH Director Dr...ecipients of the grants, designed to foster young ...ymposium at NIH headquarters Wednesday, Sept. 19. ...
...itute of Biological Sciences (AIBS), in conjunctio... will host the fourth annual symposium on evolutio...in Atlanta, Georgia. The symposium, titled Evoluti...is part of the 2007 Professional Development Confe...logy Teachers. , The aim of the symposium is to...
Other Biology News:NIH awards researcher $1.5 million 'new innovator' grant for fruit-fly studies of prion proteins 2NIH awards researcher $1.5 million 'new innovator' grant for fruit-fly studies of prion proteins 3AIBS to cohost symposium on evolution, disease and human health 2AIBS to cohost symposium on evolution, disease and human health 3AIBS to cohost symposium on evolution, disease and human health 4
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Anti-Acid Phosphatase, Potato Polyclonal Antibody, Unconjugated from CHEMICON
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Anti-Human C3a / C3a des-Arg (neo-epitope) Monoclonal Antibody, Unconjugated, Clone 2991 from Cell Sciences
Biology Products: